Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT04025541

Analysis of Circulating Tumor Markers in Blood

Led by Institut du Cancer de Montpellier - Val d'Aurelle · Updated on 2025-04-02

992

Participants Needed

2

Research Sites

574 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The circulating tumoral biomarkers in the blood are the object of numerous researches for several decades. The potential clinical interests of these circulating biomarkers are diagnostic, prognostic, predictive of the efficiency of targeted therapies (according to the mutational profile of the cancer), and could allow the study of the mechanisms of resistance under process. In the multiplicity of these blood potential biomarkers joins a permanent evolution of the technological means used to detect them/to quantify, as well as to estimate their clinical utility.

CONDITIONS

Official Title

Analysis of Circulating Tumor Markers in Blood

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient presenting an invasive tumoral pathology (proved or suspected), whatever is the location or the stage
  • Man or woman 18 years or older
  • Signed informed consent obtained before any specific preselection procedure
Not Eligible

You will not qualify if you...

  • Persons deprived of freedom or under guardianship
  • Patients unable to follow regular monitoring due to psychological, family, social, or geographical reasons
  • Pregnant or breastfeeding women
  • Patients not affiliated with the Social Protection System

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle

Montpellier, France, 34298

Actively Recruiting

2

ICM

Montpellier, France, 34298

Actively Recruiting

Loading map...

Research Team

T

texier emmannuelle

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NON_RANDOMIZED

Model

PARALLEL

Primary Purpose

DIAGNOSTIC

Number of Arms

13

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Analysis of Circulating Tumor Markers in Blood | DecenTrialz